CD274 and non-small cell lung carcinoma: Notably, significant heterogeneity exists in the expression of PD-L1 across different subtypes of NSCLC, especially between lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD), which has important implications for molecular characterization and immunotherapy strategies [27, 28].